National trends in the mortality of children with sickle cell disease, 1968 through 1992

American Journal of Public Health

Volumn 87, Issue 8, 1997, Pages 1317-1322

  Davis, Harold ^a,b   Schoendorf, Kenneth C ^c   Gergen, Peter J ^d   Moore Jr , Roscoe M ^a  

^a U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; CAUSE OF DEATH; CHILD; CHILD DEATH; COST; DISEASE CLASSIFICATION; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; PROPHYLAXIS; SICKLE CELL ANEMIA; STREPTOCOCCUS INFECTION; SURVIVAL; TREATMENT PLANNING;

EID: 0030745927     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.87.8.1317     Document Type: Article

References (35)

1. Powars D, Overturf G, Weiss J, Lee S, Chan L. Pneumococcal septicemia in children with sickle cell anemia: changing trend of survival. JAMA. 1981;245:1839-1842.
2. Gaston MH, Verter JI, Woods G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia. N Engl J Med. 1986;314:1593-1599.
3. Grover R. Newborn screening in New York City. Pediatrics. 1989;83:819-822.
4. Mack AK. Florida's experience with newborn screening. Pediatrics. 1989;83:861-863.
5. Lobel JS, Cameron BF, Johnson E, Smith D, Kalinyak K. Value of screening umbilical cord blood for hemoglobinopathy. Pediatrics. 1989;83:823-826.
6. Powars D. Diagnosis at birth improves survival of children with sickle cell anemia. Pediatrics. 1989;83:830-833.
7. Vichinsky E, Hurst D, Earles A, Kleman K, Lubin B. Newborn screening for sickle cell disease: effect on mortality. Pediatrics. 1988;81:749-755.
8. Leikin SL, Gallagher D, Kinney TR, et al. Mortality in children and adolescents with sickle cell disease. Pediatrics. 1989;84:500-508.
9. Robinson M. Clinical aspects of sickle cell disease in sickle cell anemia and other hemoglobinopathies. In: Levere R, ed. Sickle Cell Anemia and Other Hemoglobinopathies. New York, NY: Academic Press Inc; 1975:87-112.
10. Scott R. Health care priority in sickle cell anemia: special communication. JAMA. 1970;214:731-734.
11. Multiple Causes of Death. Rockville, Md: National Center for Health Statistics, Centers for Disease Control and Prevention; 1968-1992. Computer tapes.
12. Bainbridge R, Higgs DR, Maude GH, Serjeant GR. Clinical presentation of homozygous sickle cell disease. J Pediatr. 1985;106:881-885.
13. Williams S, Maude GH, Serjeant GR. Clinical presentation of sickle cell-hemoglobin C disease. J Pediatr. 1986;109:586-589.
14. Motulsky AG. Frequency of sickling disorders in U.S. blacks. N Engl J Med. 1973;288:31-33.
15. Vital Statistics of the United States, 1981, Volume 2, Mortality, Part A, Table 2-4. Washington, DC: National Center for Health Statistics; 1986. DHHS publication PHS 86-1101.
16. Guess HA, Lydick EG, Small RD, Miller LP. Epidemiologic programs for computers and calculators. Am J Epidemiol. 1987;125: 340-347.
17. Rowley PT. Prenatal diagnosis for sickle cell disease: a survey of the United States and Canada. Ann N Y Acad Sci. 1989;565: 48-52.
18. Robinson MG, Watson RJ. Pneumococcal meningitis in sickle-cell anemia. N Engl J Med. 1966;274:1006-1008.
19. Eeckels R, Gatti F, Renoirite AM. Abnormal distribution of haemoglobin genotypes in Negro children with severe bacterial infections. Nature. 1967;216:382.
20. Kabins SA, Lerner C. Fulminant pneumococcemia and sickle cell anemia. JAMA. 1970;211:467-471.
21. Zarkowsky HS, Gallagher D, Gill FM, et al. Bacteremia in sickle hemoglobinopathies. J Pediatr. 1986;109:579-585.
22. Buchanan GR, Siegel JD, Smith SJ, DePasse BM. Oral penicillin prophylaxis in children with impaired splenic function: a study in compliance. Pediatrics. 1982;70: 926-930.
23. Pegelow CH, Armstrong FD, Light S, Toledano SR, Davis J. Experience with the use of prophylactic penicillin in children with sickle cell anemia. Pediatrics. 1991; 118:736-738.
24. Sickle Cell Disease Guideline Panel. Sickle Cell Disease: Comprehensive Screening and Management in Newborns and Infants. Rockville, Md: Agency for Health Care Policy and Research; 1993. AHCPR publication 93-0563.
25. Council of Regional Networks for Genetic Services (CORN) Newborn Screening Report: 1990. New York, NY: Council of Regional Networks for Genetic Services; 1992.
26. Newborn Screening Committee. The Council of Regional Networks for Genetic Services (CORN): National Newborn Screening Report: 1992. Atlanta, Ga: Council of Regional Networks for Genetic Services; 1995.
27. Overturf GD, Selzer JW, Chan L, et al. Pneumococcal polysaccharide immunization of children with sickle cell disease: II. serologic response and pneumococcal disease following immunization. Am J Pediatr Hematol Oncol. 1982;4:25-35.
28. Broome C, Facklam RR, Fraser DW. Pneumococcal disease after pneumococcal vaccination. N Engl J Med. 1980;303:549-552.
29. Randolph L, Seidman B, Pasko T. Physician Characteristics and Distribution in the U.S. Chicago, Ill: American Medical Association; 1995.
30. Residencies and fellowships. J Pediatr. 1975;87:115.
31. Residencies and fellowships. J Pediatr. 1980;97:65-66.
32. Residencies and fellowships. J Pediatr. 1985;106:55A-56A.
33. Residencies and fellowships. J Pediatr. 1990;116:52A-54A.
34. Emond AM, Collis R, Darvill D, Higgs DR, Maude GH, Serjeant GR. Acute splenic sequestration in homozygous sickle cell disease: natural history and management. J Pediatr. 1985;107:201-206.
35. National Sickle Cell Anemia Control Act, Pub L No. 92-294 (May 16, 1972).